Incoming ethical issues for deep brain stimulation: When long-term treatment leads to a 'new form of the disease'

F Gilbert, M Lancelot - Journal of Medical Ethics, 2021 - jme.bmj.com
Deep brain stimulation (DBS) has been regarded as an efficient and safe treatment for
Parkinson's disease (PD) since being approved by the Food and Drug Administration (FDA) …

Incoming ethical issues for deep brain stimulation: when long-term treatment leads to a'new form of the disease'.

F Gilbert, M Lancelot - Journal of Medical Ethics, 2020 - europepmc.org
Deep brain stimulation (DBS) has been regarded as an efficient and safe treatment for
Parkinson's disease (PD) since being approved by the Food and Drug Administration (FDA) …

Incoming ethical issues for deep brain stimulation: when long-term treatment leads to a 'new form of the disease'

F Gilbert, M Lancelot - Journal of Medical Ethics, 2021 - search.proquest.com
Deep brain stimulation (DBS) has been regarded as an efficient and safe treatment for
Parkinson's disease (PD) since being approved by the Food and Drug Administration (FDA) …

[PDF][PDF] Incoming ethical issues for deep brain stimulation: when long-term treatment leads to a 'new form of the disease'

F Gilbert, M Lancelot - researchgate.net
Deep brain stimulation (DBS) has been regarded as an efficient and safe treatment for
Parkinson's disease (PD) since being approved by the Food and Drug Administration (FDA) …

Incoming ethical issues for deep brain stimulation: When long-term treatment leads to a 'new form of the disease'.

F Gilbert, M Lancelot - Journal of Medical Ethics: Journal of the …, 2021 - psycnet.apa.org
Deep brain stimulation (DBS) has been regarded as an efficient and safe treatment for
Parkinson's disease (PD) since being approved by the Food and Drug Administration (FDA) …

Incoming ethical issues for deep brain stimulation: when long-term treatment leads to a'new form of the disease'

F Gilbert, M Lancelot - Journal of medical ethics, 2021 - pubmed.ncbi.nlm.nih.gov
Deep brain stimulation (DBS) has been regarded as an efficient and safe treatment for
Parkinson's disease (PD) since being approved by the Food and Drug Administration (FDA) …

Incoming ethical issues for deep brain stimulation: when long-term treatment leads to a 'new form of the disease'

F Gilbert, M Lancelot - Journal of medical ethics, 2021 - ixtheo.de
Deep brain stimulation (DBS) has been regarded as an efficient and safe treatment for
Parkinson's disease (PD) since being approved by the Food and Drug Administration (FDA) …

Incoming ethical issues for deep brain stimulation: when long-term treatment leads to a 'new form of the disease'

F Gilbert, M Lancelot - Journal of Medical Ethics, 2020 - hal.science
Deep brain stimulation (DBS) has been regarded as an efficient and safe treatment for
Parkinson's disease (PD) since being approved by the Food and Drug Administration (FDA) …

Incoming ethical issues for deep brain stimulation: when long-term treatment leads to a 'new form of the disease'

F Gilbert, M Lancelot - Journal of Medical Ethics, 2020 - jme.bmj.com
Deep brain stimulation (DBS) has been regarded as an efficient and safe treatment for
Parkinson's disease (PD) since being approved by the Food and Drug Administration (FDA) …

Incoming ethical issues for deep brain stimulation: when long-term treatment leads to a 'new form of the disease'

F Gilbert, M Lancelot - Journal of Medical Ethics, 2020 - cnrs.hal.science
Deep brain stimulation (DBS) has been regarded as an efficient and safe treatment for
Parkinson's disease (PD) since being approved by the Food and Drug Administration (FDA) …